Top compounds associated with response to C18orf25


Feature Type Standardized
Nominal ANOVA
mRNA B02 CTRPv2 pan-cancer AAC 0.095 0.009
mRNA 16-beta-bromoandrosterone CTRPv2 pan-cancer AAC 0.098 0.009
mRNA Cytarabine CTRPv2 pan-cancer AAC 0.073 0.01
mRNA PHA-665752 CCLE pan-cancer AAC 0.12 0.01
mRNA tanespimycin:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.083 0.01
mRNA Topotecan CTRPv2 pan-cancer AAC 0.081 0.01
mRNA Elesclomol GDSC1000 pan-cancer AAC -0.086 0.01
mRNA AS605240 GDSC1000 pan-cancer AAC -0.082 0.01
mRNA triazolothiadiazine CTRPv2 pan-cancer AAC 0.074 0.01
mRNA tipifarnib CTRPv2 pan-cancer AAC 0.077 0.01
Download CSV